clinical-stage Videos
12 videos found
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. ...
Nov. 30, 2022
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. ...
Nov. 30, 2022
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. ...
Nov. 30, 2022
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. ...
Nov. 30, 2022
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. ...
Nov. 30, 2022
(NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Apr. 2, 2021
DiscGenics, Inc. is a privately held, clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. ...
Sep. 1, 2021
SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing ...
Mar. 25, 2022
BySafeHeal
CEO Seth Lederman talks to Proactive about the New Jersey-based clinical-stage biopharmaceutical company's 2021 highlights. Lederman says the group ended the year with $179 million in cash and cash equivalents, entering 2022 'poised for growth.' ...
Nov. 30, 2022
. ----------------------------------- About Recursion Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. ...
Jan. 23, 2023
Biotron Limited (ASX:BIT) held a webinar today to update investors on its latest news on its lead clinical stage antiviral drug BIT225. BIT225 has shown significant and clinically relevant activity in an animal model of COVID-19. The drug prevented the development of severe disease, reduced pro-inflammatory cytokines associated with "cytokine ...
Jun. 2, 2022
The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. ...
May. 31, 2022